Follistatin-344 vs MGF Peptide: Cost, Effectiveness, Side Effects Compared

Follistatin-344 at a glance:

• Drug class: Peptide hormone or growth factor
• Route: varies by compound
• Typical frequency: varies
• Half-life: varies

Both options compared on this page are legitimate choices. The differences below are real but mostly modest. The bigger swing factors are usually outside the molecule itself.

Mechanism

Follistatin-344: These peptides act on specific receptors involved in growth, reproduction, fluid balance, or other endocrine functions.

MGF Peptide: Growth hormone secretagogues stimulate endogenous GH release through either the GHRH receptor (GHRH analogs) or the GHS-R1a/ghrelin receptor (ghrelin mimetics).

For people new to this comparison, the practical takeaway is that the underlying mechanisms are different enough that response can vary.

Dosing & Administration

Effectiveness

Follistatin-344: Varies — see specific compound for details.

MGF Peptide: Increased GH and IGF-1 levels.

In head-to-head comparisons (where they exist), the higher-dose newer agents tend to outperform older ones — sometimes meaningfully.

Side Effects

The two compounds have overlapping side-effect profiles. Common to both:

• compound-specific
• injection-site reactions
• fluid retention
• joint pain
• headache

Important risks worth knowing for both:

• compound-specific
• impaired glucose tolerance
• carpal tunnel syndrome
• theoretical IGF-1-mediated effects on tumor growth

Cost

Follistatin-344: pricing varies. MGF Peptide: pricing varies.

Insurance coverage and manufacturer programs change the relative cost picture significantly. See our individual cost guides for Follistatin-344 cost and MGF Peptide cost for the latest numbers.

Which Is Right for You?

The practical decision usually comes down to four factors:

1. What's covered by your insurance? Often the deciding factor
2. What does your prescriber have experience with? Familiarity reduces dosing errors
3. How comfortable are you with injections (or oral dosing if applicable)?
4. What's your tolerance for side effects?

If you and your clinician end up split between Follistatin-344 and MGF Peptide, either is a defensible choice in most cases.

Switching Between Them

Switching from Follistatin-344 to MGF Peptide (or the reverse) is usually straightforward but should be done with clinician guidance — particularly to align dose escalation and avoid GI side effects from re-titration.

Bottom Line

If you and your clinician are split between Follistatin-344 and a comparator, you're probably in a "no wrong answer" zone. Pick the one with better access for you and reassess in 3 months.

Frequently Asked Questions

Related Reading

• Is Follistatin-344 Right for You? An Evidence-Based Breakdown
• Follistatin-344 Side Effects: 7 Things to Watch For (and How to Manage Them)
• Follistatin-344 Outcomes Decoded: Who Responds Best and Why
• How Much Does Follistatin-344 Really Cost? The Honest Breakdown
• HMG 101: A Plain-English Guide for 2026
• IGF-1 LR3 Explained: How It Works and Who It's For

Sources

• Møller N, Jørgensen JOL. Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism. Endocr Rev 2009;30:152.

This page is informational only and is not a personalized recommendation. The right choice depends on your individual situation.